Category Archives: Molecular Medicine

New Cancer Test Is Cheap, Accurate And Fast

Editor’s Choice Academic Journal Main Category: Cancer / Oncology Also Included In: Genetics Article Date: 22 Mar 2012 – 10:00 PDT email to a friend printer friendly opinions Current Article Ratings: 5 (1 votes) Current methods for identifying cancer-causing translocations have substantial shortcomings, regardless of the fact that hundreds of these translocations have already been discovered. The new pioneering technique combines microarray technology that is able to search for thousands of translocations in a single test, together with a novel antibody which is used to detect the presence of the translocation Continue reading →

Posted in Molecular Medicine | Tagged a-single-test, center, children, choice-academic, current-article, diagnostic-test, journal, journal-main, oncology, oncology-also, research, specimens-much, technique, translocation | Comments Off

Beyond the microscope: Identifying specific cancers using molecular analysis

Public release date: 19-Mar-2012 [ | E-mail | Share ] Contact: Linda Aagard 801-587-7639 University of Utah Health Sciences SALT LAKE CITY, March 19, 2012Researchers from Huntsman Cancer Institute (HCI) at the University of Utah report they have discovered a method to identify cancer-causing rearrangements of genetic material called chromosomal translocations quickly, accurately, and inexpensively. A description of the method and the research results appear online in this month’s issue of the EMBO Molecular Medicine journal. Many cancers result from chromosomal translocations in tumor cells. Continue reading →

Posted in Molecular Medicine | Tagged a-tumor-sample, analysis, cairns, children, clinical, health-sciences, research, university | Comments Off

'Snyderome' Study Suggests Much to Gain from Individual's Genome, Molecular Profiles

By Julia Karow A healthy individual’s genome sequence can help uncover disease risks that are not obvious from family history or other risk factors, and high-throughput molecular profiling in an individual over time provides unprecedented insights into disease development, according to a new study by researchers at Stanford University School of Medicine. For the study, which started about two years ago and is still ongoing, a team of researchers led by Mike Snyder, chair of Stanford’s department of genetics, generated an “integrative Personal Omics Profile,” or iPOP, of Snyder also referred to as the “Snyderome” by the study’s participants that consists of his genome sequence as well as multiple transcriptomic, proteomic, metabolomic, and autoantibody profiles over a period of 14 months. Continue reading →

Posted in Molecular Medicine | Tagged a-new-study, a-single-time, capabilities, family, genome-revealed, genome-sequence, julia-karow, medical, omics-profiles, personal, scientists, snyder, the-researchers | Comments Off

Identifying specific cancers using molecular analysis

ScienceDaily (Mar. 19, 2012) Researchers from Huntsman Cancer Institute (HCI) at the University of Utah report they have discovered a method to identify cancer-causing rearrangements of genetic material called chromosomal translocations quickly, accurately, and inexpensively Continue reading →

Posted in Molecular Medicine | Tagged a-clinician-has, analysis, clinical, google, howard-hughes, lessnick, method, project, research, science, study, technology, work | Comments Off

New information on efficacy of CLA in treating Crohn's disease

The Nutritional Immunology and Molecular Medicine Laboratory (NIMML) research team at Virginia Tech has discovered important new information on the efficacy of conjugated linoleic acid (CLA) in treating Crohn’s disease, a form of inflammatory bowel disease (IBD). CLA is a naturally occurring acid found in meat and dairy products known for its anti-cancer and immune modulatory properties Continue reading →

Posted in Molecular Medicine | Tagged afflicted-with, chapel-hill, cla, forest-medical, medicine, north, north-carolina, professor, school, study, united, united-states, university | Comments Off

Researchers discover novel therapy for Crohn's disease

Public release date: 19-Mar-2012 [ | E-mail | Share ] Contact: Tiffany Trent ttrebt@vbi.vt.edu 540-231-6822 Virginia Tech The Nutritional Immunology and Molecular Medicine Laboratory (NIMML) research team at Virginia Tech has discovered important new information on the efficacy of conjugated linoleic acid (CLA) in treating Crohn’s disease, a form of inflammatory bowel disease (IBD). CLA is a naturally occurring acid found in meat and dairy products known for its anti-cancer and immune modulatory properties. In collaboration with the Division of Gastroenterology and Hepathology at University of North Carolina School of Medicine and the Wake Forest Medical Center, researchers found that Crohn’s patients who took supplementary CLA showed noticeable improvement. Continue reading →

Posted in Molecular Medicine | Tagged a-natural-fatty, acceleration, center, director, forest-medical, nature, nimml, north-carolina, study, university, virginia | Comments Off

Molecular blood test uses biomarkers to detect kidney transplant rejection

A molecular blood test that uses biomarkers to detect renal failure following kidney transplants has been launched by Quest Diagnostics (NYSE: DGX). Continue reading →

Posted in Molecular Medicine | Tagged a-renal-biopsy, a-statement-from, because-it-has, harvard-medical, injury-or-loss, medical, medical-school, quest, statement-from | Comments Off

P4 Medicine institute, PeaceHealth Launch Partnership to Pilot New Model in Health Care

To: HEALTH, MEDICAL AND NATIONAL EDITORS Innovation consortium hopes to use breakthroughs in genome mapping and molecular diagnostics to predict and prevent disease and maintain wellness SEATTLE, March 15, 2012 /PRNewswire-USNewswire/ — PeaceHealth and the P4 Medicine institute (P4Mi) announced a partnership today that will ultimately give PeaceHealth providers additional innovative care tools and technologies to predict and potentially delay and / or avoid disease in patients through breakthroughs in genome mapping and molecular diagnostics. The P4 Medicine institute selected PeaceHealth, a regional healthcare system serving rural, suburban and urban communities in Alaska, Washington and Oregon, as its founding community health partner. Continue reading →

Posted in Molecular Medicine | Tagged founding, health, healthcare, june, medicine, modern, oregon, participation, peace, president, seattle, seattle-based, thomson-reuters | Comments Off

Quest Diagnostics Launches First Molecular Test for Kidney Organ Transplant Rejection

MADISON, N.J., March 15, 2012 /PRNewswire/ — Quest Diagnostics (NYSE: DGX – News), the world’s leading provider of diagnostic testing, information and services, today announced the availability of the industry’s first molecular blood test for identifying renal (kidney) organ-transplant rejection. The Renal TransplantMonitoring laboratory-developed test is designed to help physicians detect kidney failure weeks before conventional tests or clinical symptoms signify damage. Continue reading →

Posted in Molecular Medicine | Tagged a-2007-report, england-journal, harvard-medical, human-leukocyte, industry, medical, medical-college, medicine, nephrology, potential, quest, scientific | Comments Off

MolecularHealth Names Drug Safety and Personalized Medicine Expert Lawrence J. Lesko as Scientific Advisor

NEW YORK, March 14, 2012 /PRNewswire/ – MolecularHealth, a leader in clinico-molecular informatics ™ , today announced that Larry Lesko, Ph.D., F.C.P., former Director of the Office of Clinical Pharmacology … Continue reading →

Posted in Molecular Medicine | Tagged clinical, clinical-pharmacology, director, larry, larry-lesko, march, new, office, today-announced, york | Comments Off

EMBO Molecular Medicine to join Wiley Open Access publishing program

Wiley-Blackwell, the scientific, technical, medical and scholarly publishing business of John Wiley & Sons, Inc., and EMBO today announced that EMBO Molecular Medicine will, as of March 2012, join the Wiley Open Access publishing program. Articles in the journal will be open access and free to view, download and share for non-commercial use Continue reading →

Posted in Molecular Medicine | Tagged category-with, chief-editor, dissemination, impact-factor, institute-, journal, medicine, molecular-medicine, placing-it-6th, science, technology, university, visibility, wiley | Comments Off

Sequenom, Inc. Reports Financial Results for the Fourth Quarter and Full-Year of 2011

SAN DIEGO, March 7, 2012 /PRNewswire/ — Sequenom, Inc. (NASDAQ: SQNM – News), a life sciences company providing innovative genetic analysis solutions, today reported total revenues of $15.5 million and $55.9 million for the fourth quarter and full-year of 2011, respectively. Continue reading →

Posted in Molecular Medicine | Tagged a-pivotal-year, expansion, fourth, from-the-launch, full, materni, sequenom, sequenom-as-the | Comments Off

Randox Molecular Diagnostics Strategy Takes Shape with Pending Launch of Three New Tests

By Ben Butkus Clinical diagnostics firm Randox Laboratories this quarter expects to receive the CE IVD Mark for a trio of multiplex molecular diagnostic panels to detect respiratory pathogens, sexually transmitted infections, and KRAS/BRAF/PIK3CA mutations, a company official said this week. Continue reading →

Posted in Molecular Medicine | Tagged assay-chemistry, combines-highly, different-types, insider, making-it-the, microarray, molecular, randox, week, well-as-several | Comments Off

Jonathan Stamler named director, Bob Keith to head drug development of Harrington project

CLEVELAND, Ohio Jonathan Stamler, the newly named Director ofUniversity Hospitals Harrington Discovery Institute, was lured from a productive 15-year cardiovascular research career at Duke University in 2009 to head up University Hospitals’ fledgling Institute for Transformational Molecular Medicine. Continue reading →

Posted in Molecular Medicine | Tagged career, catalyst-growth, family, harrington, harvard-medical, pharmaceutical, research, summer, university | Comments Off

International meet on molecular medicine begins at SBCE

Small changes in the molecules might cause diseases and discovering new drugs through molecular research was the only solution to address the problem, said Prof V.N. Continue reading →

Posted in Molecular Medicine | Tagged a-much-greater, a-patients-were, a-slight-change, afternoon, biotechnology, department, dna, malaysia, medical, president, science, sickle-cell, society, technology | Comments Off

Molecular Insight Pharmaceuticals Elects a New Board of Directors

More Topics: Choose a Sector Accounting Firms Advertising/Media/Communications Capital CEO/Board General Business Health/Biotech Internet/Technology Investment Firms Law Firms Mergers & Acquisitions Money Managers People Private Companies Public Companies Venture Capital Posted February 23, 2012 Board Members to Help Guide Restructured Company Toward Prostate Cancer Focused Strategy; Update on Clinical Development Programs CAMBRIDGE, MA — Molecular Insight Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company and pioneer in the field of molecular medicine, announced today that it has elected a new Board of Directors. The new Board will support the Company's strategic focus on the discovery, development, and commercialization of radiopharmaceuticals for molecular imaging and targeted radiotherapy of prostate cancer. Continue reading →

Posted in Molecular Medicine | Tagged a-strategic-and, chairman, discovery, health, molecular, molecular-insight, officer, topics | Comments Off

Molecular Insight Pharmaceuticals, Inc. Elects a New Board of Directors

CAMBRIDGE, MA–(Marketwire -02/23/12)- Molecular Insight Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company and pioneer in the field of molecular medicine, announced today that it has elected a new Board of Directors. The new Board will support the Company's strategic focus on the discovery, development, and commercialization of radiopharmaceuticals for molecular imaging and targeted radiotherapy of prostate cancer Continue reading →

Posted in Molecular Medicine | Tagged a-more-accurate, board, discovery, information, management, molecular, molecular-insight, officer | Comments Off

ImmunoCellular Therapeutics To Present at Targeting Stem Cells Symposium during 19th Annual Molecular Medicine Tri …

LOS ANGELES–(BUSINESS WIRE)– ImmunoCellular Therapeutics, Ltd. (“ImmunoCellular” or the “Company”) (OTCBB: IMUC –News), a biotechnology company focused on the development of novel immune-based cancer therapies, today announced that John Yu, MD, Chairman and Chief Scientific Officer of ImmunoCellular Therapeutics, will deliver a presentation at the Cambridge Healthtech Institute’s inaugural Targeting Stem Cells Symposium as a part of the 19th Annual Molecular Medicine Tri-Conference from February 19-23, 2012. Dr. Continue reading →

Posted in Molecular Medicine | Tagged cambridge, cells-symposium, cellular-therapeutics, chairman, development, imuc, press-release, reports-on-form, risk, targeting-stem, therapeutics- | Comments Off

New MDC Research Report published

Public release date: 17-Feb-2012 [ | E-mail | Share ] Contact: bachtler@mdc-berlin.de bachtler@mdc-berlin.de 49-309-406-3896 Helmholtz Association of German Research Centres The Max Delbr?ck Center for Molecular Medicine (MDC) Berlin-Buch, which celebrates its 20th anniversary this year, has published its latest research report. In the 298-page book that is primarily written in English, all of the 67 research groups of the MDC and the clinical groups in the Experimental and Clinical Research Center (ECRC) of the MDC and of the Charit? ? Universit?tsmedizin Berlin give an overview of their work in 2010 ? 2011. Continue reading →

Posted in Molecular Medicine | Tagged campus-berlin-, charit, clinical, countries, education, german, helmholtz, medical, press, professor, research, work | Comments Off

Plethora of New Products to be Showcased at 2012 Molecular Medicine Tri-Conference

Needham, MA (PRWEB) February 17, 2012 Cambridge Healthtech Institute announces 47 exhibitors & sponsors to showcase new products at the 19th Molecular Medicine Tri-Conference, taking place February 19-23, at the Moscone North Convention Center, San Francisco, CA. The Molecular Medicine Tri-Conference is the predominant event on the west coast focused on integrating the entire spectrum of drug development. The Molecular Medicine Tri-Conference has experienced seven straight years of attendee growth, while maintaining a high quality audience Continue reading →

Posted in Molecular Medicine | Tagged analysis, business, cambridge, dna, fish, information, medicine, nirvana, oncology, open-source, optimization, research, science | Comments Off